Stanford University - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Stanford University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stanford University - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Stanford University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
53 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Stanford University is an educational and research organization that provides graduate and undergraduate programs. The organizations services include education and research facilities. It offers research facilities through its research laboratories and centers. Stanford University includes graduate school of business, school of earth, energy and environmental sciences, graduate school of education, school of engineering, school of humanities and sciences, law school and school of medicine. The organization's academic programs include continuing studies, pre-collegiate studies and degrees.

Stanford University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of eac

  
Source:
Document ID
GDPH66974D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Stanford University, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201652
Stanford University, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201671
Stanford University, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201681
Stanford University, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201691
Stanford University, Medical Devices Deals, 2010 to YTD 2016101
Stanford University, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016113
Stanford University, Pharmaceuticals &Healthcare, Deal Details1435
  Venture Financing141
    Arcus Biosciences Raises USD70 Million in Venture Financing142
  Partnerships161
    RedHill Biopharma Enters into Research Agreement with Stanford University School of Medicine161
    twoXAR Enters into Agreement with Stanford University School of Medicine171
    twoXAR Enters into Research Agreement with Stanford University181
    Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center191
    SRI Biosciences Enters into Agreement with Stanford Cancer Institute201
    ImmunoCellular Therapeutics Enters into Research Agreement with Stanford University211
    SRI Biosciences Enters into Agreement with Stanford Cancer Institute221
    aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery232
    Activaero Enters Into Research Agreement With Stanford University251
    Benitec Biopharma Enters Into An Agreement With Stanford University261
    Sanofi-aventis Enters Into Research Collaboration With Bio-X Stanford University271
    Salinas Valley Memorial Healthcare Forms Joint Venture With Stanford Hospital &Clinics281
    VLife Sciences Technologies Enters Into Agreement With NCBS, Stanford University And Technical University Of Denmark292
  Licensing Agreements311
    Forty Seven Enters into Licensing Agreement with Stanford University311
    Medgenics Enters into Licensing Agreement with Stanford University321
    Eiger BioPharma Enters into Licensing Agreement with Stanford University for Post-Bariatric Surgical Hypoglycemia331
    Eiger BioPharma Enters into Licensing Agreement with Stanford University341
    Eiger BioPharma Enters into Licensing Agreement with Stanford University for Pulmonary Arterial Hypertension351
    Abeona Therapeutics Enters into Licensing Agreement with Stanford University361
    Horizon Discovery Enters into Licensing Agreement with Stanford University371
    Neurotrope Enters into Licensing Agreement with Stanford University381
    Globavir Enters into Licensing Agreement with Stanford University391
    Quest PharmaTech Enters Into Licensing Agreement With Stanford University For Anti-MUC1 IgE Technology401
    Personalis Enters Into Licensing Agreement With Stanford University411
    Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology421
    Stem Cell Theranostics Enters into Agreement with Stanford University431
    Transparency Life Sciences Enters Into Option Licensing Agreement With Stanford University441
    SiteOne Therapeutics Enters into Licensing Agreement with Stanford University451
    AIDS Research Enters Into Licensing Agreement With Stanford University461
  Acquisition471
    Stanford Health Care Acquires ValleyCare Health471
    Stanford Hospital Acquires CareCounsel Health Advocacy Specialist481
Stanford University - Key Competitors491
Key Employees501
Locations And Subsidiaries512
  Head Office511
  Other Locations &Subsidiaries512
Appendix531
  Methodology531
  About GlobalData531
  Contact Us531
  Disclaimer531

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Stanford University - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Stanford-University-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17207>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Stanford University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Stanford-University-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17207>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research